Neuraxis Inc — Cash Flow (NYSE:NRXS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities -6.69 M-6.1 M-6.43 M -6.43 M Cash from investing activities -71.78 K-27.78 K-131.15 K -131.15 K Cash from financing activities 6.59 M9.74 M7.83 M 7.83 M Free cash flow -6.77 M-6.13 M-6.56 M -6.46 M

뉴스

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis

Top Stock Reports for Meta, Bank of America & Procter & Gamble

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth

뉴라시스, FDA 승인 후 주가 상승: 복통 치료제

Neuraxis stock rises after FDA clearance for abdominal pain treatment

FDA, 뉴라시스 PENFS 기기 승인 및 시장 확대

뉴라시스, 2025년 3분기 예비 실적 발표...210만 달러 영업 손실

Neuraxis reports preliminary Q3 2025 financial results with $2.1 million operating loss

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis

Top Research Reports for Alphabet, IBM & Merck

Neuraxis enters $3.3 million at-the-market equity offering agreement